Drug pricing
California signs into law transparency over drug pricing
October 10, 2017Manufacturing and Production, Sales and Marketing Drug pricing, biotech, california, drugs, pharma, pharmaceutical
In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement …
FDA to expedite complex generic approvals to lower drug prices through competition
October 3, 2017Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, FDA, generics, pharma, pharmaceutical
In the midst of ongoing discussions over drug pricing, the FDA has announced plans to facilitate accelerated access to generic …
Regulators get aggressive on matters excessive
June 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen
Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …
FDA’s Gottlieb draws those ‘gaming’ system into pricing debate
June 22, 2017Medical Communications, Sales and Marketing Drug pricing, FDA, Trump
President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …
Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?
February 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn
As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …
1,100% generic cancer drug price increases fly below UK radar
January 30, 2017Manufacturing and Production, Sales and Marketing Drug pricing, European Cancer congress
If you were asked what the big topic of discussion in the pharmaceutical industry was last year, there would really …
MSD puts best foot forward in drug pricing debate
January 30, 2017Medical Communications, Sales and Marketing Drug pricing, MSD, Merck
MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …
Pfizer sues Texas agency over leak of drug prices
November 21, 2016Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas
Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …
Proposition 61 defeated to allay changes on drug pricing
November 11, 2016Medical Communications Bernie Sanders, Drug pricing, Proposition 61, california
Another major piece of voting news emerged on 9 November, with Proposition 61 voted down by Californian residents, with the …
Clinton announces plan to tackle “unjustified price hikes”
September 5, 2016Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes
US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …
American pharmacy adds 35 products to list of excluded drugs
August 4, 2016Sales and Marketing Drug pricing, cvs health, excluded drugs, hyperinflationary
American pharmacy chain CVS Health has added 35 products to its list of excluded drugs and will not cover certain …
The ethical battle for the future of pharma
July 25, 2016Drug pricing, ethics in pharma
A battle is raging for the soul of the pharma industry and the stakes are high. Those companies seeking to …
Drug Pricing: Cancer drugs cost the most in US, but most unaffordable in India, China – Study
June 7, 2016Medical Communications, Research and Development, Sales and Marketing ASCO, Drug pricing, oncology, social
Cancer drugs are less affordable in low-income countries, despite the lower retail prices, according to a study released at the …
Focus: Regulators Enter the Drug Pricing Debate
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, pharma industry, regulation
By Anjali Shukla The Chinese authorities have come down strongly on the issue of drug costs, slashing the prices of …
France to push for drug price control regulations at upcoming G7 summit
May 3, 2016Manufacturing and Production Drug pricing, France, drug prices, g7 summit, hollande, irreversible, medicines, pharmaceutical, prices
France will urge its fellow G7 partners to introduce strict and final new limits to control the prices of new …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
